SynthesisFrontiers in endocrinology2026

SGLT2 versus DPP-4 inhibitors in type 2 diabetes: a meta-analysis of outcomes.

Xiancong Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.